[go: up one dir, main page]

AR078906A1 - Proceso para la preparacion de calcobutrol - Google Patents

Proceso para la preparacion de calcobutrol

Info

Publication number
AR078906A1
AR078906A1 ARP100104075A ARP100104075A AR078906A1 AR 078906 A1 AR078906 A1 AR 078906A1 AR P100104075 A ARP100104075 A AR P100104075A AR P100104075 A ARP100104075 A AR P100104075A AR 078906 A1 AR078906 A1 AR 078906A1
Authority
AR
Argentina
Prior art keywords
tetraazacyclododecane
dihydroxy
hydroxymethyl
propyl
complex
Prior art date
Application number
ARP100104075A
Other languages
English (en)
Inventor
Johannes Platzek
Wilhelm Trentmann
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43297060&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR078906(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of AR078906A1 publication Critical patent/AR078906A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00Compounds containing elements of Groups 2 or 12 of the Periodic Table
    • C07F3/04Calcium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)

Abstract

Reivindicacion 1: El complejo con calcio del ácido 10-(2,3-Dihidroxi-1-(hidroximetil)propil)-1,4,7,10-tetraazaciclododecano-1,4,7-triacético con una pureza del 99,0% o más. Reivindicacion 2: El complejo de acuerdo con la reivindicacion 1 con una pureza del 99,4% o más. Reivindicacion 4: Un proceso para la preparacion del complejo con calcio del ácido 10-(2,3-Dihidroxi-1-(hidroximetil)propil)1,4,7,10-tetraazaciclododecano-1,4,7-triacético (Calcobutrol), donde se siguen los siguientes pasos: a) descomplejar el complejo con gadolinio del ácido 10-(2,3-Dihidroxi-1-(hidroximetil)propil)-1,4,7,10-tetraazaciclododecano-1,4,7-triacético (Gadobutrol) con un agente descomplejante, b) separar la sal de gadolinio que precipita, c) unir al ligando que está libre en la solucion que se obtiene como resultado del paso b) a una resina de intercambio ionico ácida, d) eluir dicha resma con una solucion alcalina acuosa, e) tratar el eluato con resina de intercambio ionico ácida, y f) complejar el ligando con iones Ca+2 y cristalizarlo.
ARP100104075A 2009-11-04 2010-11-04 Proceso para la preparacion de calcobutrol AR078906A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102009053171A DE102009053171B4 (de) 2009-11-04 2009-11-04 Verfahren zur Herstellung des Calcium-Komplexes von Dihydroxy-hydroxy-methylpropyl-tetraazacyclododecan-triessigsäure (Calcobutrol)

Publications (1)

Publication Number Publication Date
AR078906A1 true AR078906A1 (es) 2011-12-14

Family

ID=43297060

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP100104075A AR078906A1 (es) 2009-11-04 2010-11-04 Proceso para la preparacion de calcobutrol

Country Status (35)

Country Link
US (1) US9447053B2 (es)
EP (2) EP2496562B1 (es)
JP (1) JP5733800B2 (es)
KR (3) KR20120093388A (es)
CN (1) CN102164901B (es)
AR (1) AR078906A1 (es)
AU (1) AU2010317166C1 (es)
BR (1) BR112012010320B1 (es)
CA (1) CA2777314C (es)
CL (1) CL2012001172A1 (es)
CO (1) CO6551758A2 (es)
CR (1) CR20120235A (es)
CU (1) CU24105B1 (es)
CY (1) CY1115051T1 (es)
DE (1) DE102009053171B4 (es)
DK (1) DK2496562T3 (es)
DO (1) DOP2012000126A (es)
EA (2) EA201300789A1 (es)
EC (1) ECSP12011866A (es)
ES (1) ES2462970T3 (es)
HR (1) HRP20140399T1 (es)
IL (1) IL219012A0 (es)
MX (1) MX2012005283A (es)
MY (1) MY158421A (es)
NZ (2) NZ599705A (es)
PE (1) PE20130224A1 (es)
PH (1) PH12012500891A1 (es)
PL (1) PL2496562T3 (es)
PT (1) PT2496562E (es)
RS (1) RS53287B (es)
SI (1) SI2496562T1 (es)
TW (1) TWI473794B (es)
UY (1) UY33002A (es)
WO (1) WO2011054827A1 (es)
ZA (1) ZA201202504B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2780599T3 (es) 2011-04-21 2020-08-26 Bayer Ip Gmbh Preparación de gadobutrol de alta pureza
EP2786768A1 (en) 2013-04-04 2014-10-08 Agfa Healthcare Process for preparing a material comprising a macrocyclic ligand and for producing a pharmaceutical formulation comprising said ligand with a lanthanide
KR101693400B1 (ko) 2014-09-17 2017-01-05 에스티팜 주식회사 칼코부트롤의 제조방법
KR101646211B1 (ko) * 2014-11-12 2016-08-05 (주)디아이테크 자기공명영상용 조영제의 제조방법
EP3101012A1 (en) 2015-06-04 2016-12-07 Bayer Pharma Aktiengesellschaft New gadolinium chelate compounds for use in magnetic resonance imaging
CN105037288B (zh) * 2015-07-23 2017-11-03 上海现代制药海门有限公司 一种布醇的制备方法
CN106620726B (zh) * 2015-10-29 2020-10-02 山东威智百科药业有限公司 一种钆布醇注射液及其制备方法
CN106187930B (zh) * 2016-07-12 2018-10-19 嘉实(湖南)医药科技有限公司 高纯度考布曲钙的制备方法
HUE050553T2 (hu) * 2016-09-27 2020-12-28 Bayer Pharma AG Eljárás A módosulatú kalkobutrol kristályos alakjának elõállítására
WO2018096082A1 (en) 2016-11-28 2018-05-31 Bayer Pharma Aktiengesellschaft High relaxivity gadolinium chelate compounds for use in magnetic resonance imaging
CN109384737A (zh) * 2017-08-04 2019-02-26 天津科伦药物研究有限公司 一种四氮杂环钇络合物及其制备方法和应用
KR101971435B1 (ko) * 2017-08-29 2019-04-24 주식회사 엔지켐생명과학 가도부트롤 중간체 및 이를 이용한 가도부트롤의 제조 방법
KR20190088793A (ko) * 2018-01-19 2019-07-29 주식회사 엔지켐생명과학 칼코부트롤의 제조방법
EP3820853A4 (en) 2018-07-10 2022-08-17 Biophore India Pharmaceuticals Pvt. Ltd. PROCESS FOR THE PREPARATION OF 2,2',2''-(10-((2R,3S)-1,3,4-TRIHYDROXY BUTAN-2-YL)-1,4,7,10-TETRAAZACYCLODODECANE-1 ACID ,4,7-TRIYL) TRIACETIC AND ITS COMPLEXES
WO2020084504A1 (en) * 2018-10-24 2020-04-30 Biophore India Pharmaceuticals Pvt. Ltd Novel process for the preparation of macrocyclic chelant 2,2',2''-(10-(2-hydroxypropyl)-1,4,7,10-tetra azacyclododecane-1,4,7-triyl) triacetic acid and it's complexes with paramagnetic metal ions
AU2019382881B2 (en) * 2018-11-23 2025-06-12 Bayer Aktiengesellschaft Formulation of contrast media and process of preparation thereof
KR101979836B1 (ko) * 2019-01-02 2019-05-21 동국생명과학 주식회사 칼코부트롤의 제조방법
CN111039885B (zh) * 2019-12-06 2021-03-05 广州康瑞泰药业有限公司 一种制备高纯度考布曲钙的方法
US11667601B2 (en) 2019-12-20 2023-06-06 Bracco Imaging S.P.A. Calcium BOPTA complex
KR20210112910A (ko) 2020-03-06 2021-09-15 주식회사 엔지켐생명과학 가도부트롤 주사제 제조를 위한 부형제인 칼코부트롤의 제조 방법
KR20210114742A (ko) * 2020-03-11 2021-09-24 주식회사 엔지켐생명과학 칼테리돌의 제조방법
CN114573522A (zh) * 2020-11-30 2022-06-03 江苏恒瑞医药股份有限公司 一种考布曲钙的新晶型及其制备方法
CN115779105B (zh) * 2022-11-17 2025-05-27 华润双鹤药业股份有限公司 一种钆布醇注射液及其制备方法
CN119143689B (zh) * 2024-11-15 2025-05-30 苏州美诺医药科技有限公司 考布曲钙和其中间体的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3625417C2 (de) 1986-07-28 1998-10-08 Schering Ag Tetraazacyclododecan-Derivate
DE3640708C2 (de) * 1986-11-28 1995-05-18 Schering Ag Verbesserte metallhaltige Pharmazeutika
DE4009119A1 (de) 1990-03-19 1991-09-26 Schering Ag 1,4,7,10-tetraazacyclododecan-butyltriole, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
IE910955A1 (en) 1990-03-23 1991-09-25 Yamanouchi Europ Bv Il-6 inhibiting compositions
DE4237943C2 (de) * 1992-11-06 1997-10-23 Schering Ag Verfahren zur Herstellung von Metallkomplexen der N-beta-Hydroxyalkyl-tri-N-carboxyalkyl-1,4,7,10-tetraazacyclododecan- und N-beta-Hydroxyalkyl-tri-N-carboxyalkyl-1,4,8,11-tetraazacyclotetradecan-Derivate
DE4218744C2 (de) * 1992-06-04 1997-11-06 Schering Ag Verfahren zur Herstellung von N-ß-Hxdroxyalkyl-tri-N-carboxylalkyl-1,4,7,10-tetraazacyclododecan- und N-ß-Hydroxyalkyl-tri-N-carboxyalkyl-1,4,8,11-tetraazacyclotetradecan-Derivaten und deren Metallkomplexe
IT1275426B (it) 1995-05-16 1997-08-07 Bracco Spa Recupero del gadolinio e dei suoi agenti complessanti da soluzioni acquose contenenti i loro complessi
DE19724186C2 (de) * 1997-06-02 2002-07-18 Schering Ag Verfahren zur Mono- und 1,7-Bis-N-ß-Hydroxyalkylierung von Cyclen und die entsprechenden N-ß-Hydroxyalkyl-1,4,7,10-tetraazacyclododecan-Li-Salz-Komplexe
IT1292130B1 (it) 1997-06-11 1999-01-25 Bracco Spa Processo per la preparazione dell'acido 1,4,7,10-tetraazaciclododecan -1,4,7-triacetico e suoi derivati
IT1293778B1 (it) 1997-07-25 1999-03-10 Bracco Spa 1,4,7,10-tetraazabiciclo(8.2.2.)tetradecan-2 one, sua preparazione e suo uso per la preparazione di tetraazamacrocicli
US9016221B2 (en) * 2004-02-17 2015-04-28 University Of Florida Research Foundation, Inc. Surface topographies for non-toxic bioadhesion control
WO2011054480A1 (de) * 2009-11-09 2011-05-12 Bayer Schering Pharma Aktiengesellschaft Gadobutrolherstellung mittels keramischer membran

Also Published As

Publication number Publication date
NZ599705A (en) 2014-03-28
PL2496562T3 (pl) 2014-07-31
DE102009053171B4 (de) 2011-07-21
CR20120235A (es) 2012-08-01
EA020161B9 (ru) 2018-11-30
KR20110086885A (ko) 2011-08-01
TW201139387A (en) 2011-11-16
CL2012001172A1 (es) 2012-09-14
DK2496562T3 (da) 2014-05-12
EA020161B1 (ru) 2014-09-30
TWI473794B (zh) 2015-02-21
PT2496562E (pt) 2014-05-13
AU2010317166B2 (en) 2014-11-27
EP2599777A1 (en) 2013-06-05
CY1115051T1 (el) 2016-12-14
DOP2012000126A (es) 2012-08-15
NZ612449A (en) 2015-01-30
CA2777314C (en) 2017-09-12
EP2496562B1 (en) 2014-02-12
BR112012010320A2 (pt) 2016-03-29
AU2010317166C1 (en) 2019-02-28
CU24105B1 (es) 2015-07-30
IL219012A0 (en) 2012-06-28
MX2012005283A (es) 2012-10-05
ECSP12011866A (es) 2012-07-31
JP5733800B2 (ja) 2015-06-10
KR20110058746A (ko) 2011-06-01
CA2777314E (en) 2011-05-12
ES2462970T3 (es) 2014-05-27
AU2010317166A1 (en) 2012-05-03
EA201300789A1 (ru) 2013-12-30
HRP20140399T1 (hr) 2014-06-06
CN102164901B (zh) 2015-03-11
HK1161237A1 (en) 2012-08-24
KR101057939B1 (ko) 2011-08-18
PH12012500891A1 (en) 2012-11-12
KR101251210B1 (ko) 2013-04-08
CA2777314A1 (en) 2011-05-12
MY158421A (en) 2016-10-14
UY33002A (es) 2011-06-30
CU20120072A7 (es) 2012-10-15
DE102009053171A1 (de) 2011-05-05
RS53287B (sr) 2014-08-29
EA201200652A1 (ru) 2012-12-28
US9447053B2 (en) 2016-09-20
PE20130224A1 (es) 2013-03-06
JP2013510117A (ja) 2013-03-21
SI2496562T1 (sl) 2014-06-30
WO2011054827A1 (en) 2011-05-12
ZA201202504B (en) 2013-06-26
CO6551758A2 (es) 2012-10-31
US20120309962A1 (en) 2012-12-06
EP2496562A1 (en) 2012-09-12
KR20120093388A (ko) 2012-08-22
BR112012010320B1 (pt) 2019-05-14
CN102164901A (zh) 2011-08-24

Similar Documents

Publication Publication Date Title
AR078906A1 (es) Proceso para la preparacion de calcobutrol
CO6362053A2 (es) Extracción de uranio a partir de ácido fosfórico de proceso húmedo
CL2017000989A1 (es) Proceso para extracción de metales con lixiviación y sorción en sólidos húmedos
BR112015021932A2 (pt) método para sequestrar cátions que podem se precipitar a partir de uma composição aquosa, e, aparelho para dessalinização preventiva de incrustação
BR112015017675A2 (pt) processo para a produção de 1, 4, 7, 10 – tetraazaciclododecano-1, 4, 7, 10-ácido tetra acético e complexos do mesmo
EA019279B9 (ru) Способ очистки бикарбоната лития
JO3750B1 (ar) إعادة تمعدن مياه التحلية والنقية من خلال المعالجة بمحلول كربونات الكالسيوم في المياه اليسره
PT2125620E (pt) Produção de tório 228 a partir de um sal de tório natural
CO6501128A2 (es) Metodo para realizar una composicion antitranspirante anhidra liquida
CA2618326A1 (en) Method for manufacturing scorodite
CL2012003214A1 (es) Metodo para tratar una solucion acida que contiene iones yoduro y iones hierro (ii), que comprende oxidar los iones hierro en dicha solucion a iones hierro (iii) mediante microorganismos oxidantes del hierro, donde la oxidacion se efectua en presencia de carbon activado; y metodo para la lixiviacion de cobre a partir de una mena de sulfuro de cobre.
CO7200258A2 (es) Silicato de zirconio microporoso para el tratamiento de la hipercalemia en pacientes hipercalcémicos y composiciones con calcio mejoradas para el tratamiento de la hipercalemia
UA113204C2 (xx) Селективна екстракція хлориду калію з відхідного шенітового розчину з використанням тартратної кислоти як безпечного м'якого екстрагента, придатного до рециркуляції
CL2007002747A1 (es) Proceso para tratar cobre obtenido por precipitacion electrolitica que comprende una primera etapa de lixiviacion con acido sulfurico, agregar oxigeno, agitar la solucion, y luego separar la solucion lixiviada que contiene as pentavalente y una segun
TN2015000372A1 (en) A method for concentrating rare-earth metals in phosphogypsum
PH12015500744A1 (en) Layered double hydroxides
AR075888A1 (es) Metodo para tratar una corriente de biodiesel que contiene impurezas
CL2015002889A1 (es) Método para recuperar oro a partir de mineral de sulfuro.
GR1007843B (el) Προσροφητικο υλικο για την απομακρυνση φωσφορου και αμμωνιας
RU2011147500A (ru) Способ извлечения урана из маточных растворов
IN2012DN04900A (es)
AR072698A1 (es) Procedimiento para acondicionar sustancias organicas y metales que se presentan en forma ionica en la solucion de desecho que se obtiene en la limpieza por via quimica humeda de instalaciones de tecnica convencional o de tecnica nuclear
JP2011527233A5 (es)
MX355707B (es) Proceso de purificacion para celulosa parcialmente hidrolizada.
RU2010104078A (ru) Способ ионной имплантации конструкционной стали ионами меди

Legal Events

Date Code Title Description
FG Grant, registration